News Detail
New Delhi, 1 April 2024: The National Pharmaceutical Pricing Authority (NPPA) has deferred fixing retail prices of 11 drug formulations manufactured by Delhi-based Synokem Pharmaceuticals for various marketing companies for want of information from the drug regulator on whether t......
View Details
Source : Pharmabiz
National Pharmaceutical Pricing Authority
NPPA
Synokem Pharmaceuticals
Drugs Prices Control Order
DCGI
SLA
CDSCO
dapagliflozin
vildagliptin
sitagliptin
teneliglipt
telmisartan
cilnidipine
Related News
- NPPP 2012 lays down the regulatory framework for pricing of drugs (05-02-2025)
- Government Tightens Drug Quality Regulations (05-02-2025)
- UCPMP 2024 to prevent unethical marketing (05-02-2025)
- Addressing the Issue of Blood Black Marketing: The Need for Regulatory Measures (05-02-2025)
- Pharmacist arrested for deceiving female officers by impersonating an IAS officer (05-02-2025)
- Assam Rifles seized 6,900 Eskuf Cough Syrup Bottles worth Rs. 40 lakh from Nagicherra (04-02-2025)
- Illegal Call Center Busted in Sakinaka: 6 Arrested, Electronic Devices Seized (04-02-2025)
- IIT Guwahati researchers develop new trial method for personalised care (04-02-2025)
- Team will go to the companies making heavy doses of narcotic drugs, after checking the records, will ban them from supplying them (04-02-2025)
- Henkel introduces new light cure adhesives for the assembly of flexible medical devices (03-02-2025)